Physician
Wang, Enmei
Wang, Enmei was paid $188K by Medicaid between Feb 2018 and Mar 2023, across 14 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 41% of everything it billed.
33Billing provider infoWANG, ENMEI
WAKEFIELD, MA 01880
WAKEFIELD, MA 01880
33aNPI1295775724assigned 06/06/2006
33bProvider typePediatrics Physician
28Total paid$188K
24GClaims5,230
24DCodes billed14
24AFirst – last monthFeb 2018 – Mar 2023
Compared with peers
Next to other Pediatrics Physician providers in Massachusetts
Rank by total paid#301 of 1,273
Median peer was paid$24K
This provider vs. median7.8×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 910 | $31K | |
| 2019 | 1,130 | $39K | |
| 2020 | 783 | $21K | |
| 2021 | 1,161 | $45K | |
| 2022 | 1,073 | $42K | |
| 2023 | 173 | $8K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 41% | 1,355 | 1,246 | $76K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 25% | 485 | 437 | $47K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 15% | 997 | 832 | $29K |
| S0302 | Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) | 5.3% | 1,094 | 1,083 | $10K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 3.2% | 116 | 112 | $6K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 1.9% | 324 | 323 | $4K |
| 96127 | 1.6% | 261 | 257 | $3K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 1.2% | 72 | 71 | $2K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.2% | 192 | 114 | $2K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 1.1% | 26 | 26 | $2K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 1.0% | 83 | 80 | $2K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 152 | 145 | $2K |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.